Search results
Results from the WOW.Com Content Network
Deborah Leah Birx (born April 4, 1956) is an American physician and diplomat who served as the White House Coronavirus Response Coordinator under President Donald Trump from 2020 to 2021. Birx specializes in HIV/AIDS immunology, vaccine research, and global health. [1]
The Biden administration said it has suspended from all federal funding programs the scientist at the heart of the lab leak theory of the origins of the coronavirus, and proposed blocking him from ...
In June 2021, as Mississippi was one of five U.S. states with less than 35% of its population vaccinated, Dr. Scott Gottlieb, former commissioner of the U.S. Food and Drug Administration, predicted the state was at risk for outbreaks of the Delta variant.
Corbett is among a cohort of recent UMBC graduates (also including Kaitlyn Sadtler) who have risen to prominence in biomedicine during the COVID-19 pandemic. In 2014, Corbett received a PhD in microbiology and immunology from the University of North Carolina at Chapel Hill.
JACKSON, Miss. (AP) — Medicaid expansion efforts fizzled and died Thursday in Republican-led Mississippi because top lawmakers could not agree on a final proposal to send to the House and Senate.
Neil Morris Ferguson OBE FMedSci (born 1968) is a British epidemiologist and professor of mathematical biology, who specialises in the patterns of spread of infectious disease in humans and animals.
JACKSON, Miss. (AP) — Mississippi Senate leaders on Friday said for the first time that they are willing to expand Medicaid to the full level allowed under a federal law signed 14 years ago by...
The timeline of the COVID-19 pandemic lists the articles containing the chronology and epidemiology of SARS-CoV-2, the virus that causes the coronavirus disease 2019 and is responsible for the COVID-19 pandemic. The first human cases of COVID-19 occurred in Wuhan, People's Republic of China, on or about 16 November 2019.
For premium support please call: 800-290-4726 more ways to reach us
One of Didier's COVID-19 studies was later retracted by the International Journal of Antimicrobial Agents. On March 28, the FDA issued an Emergency Use Authorization (EUA) which allowed certain hospitalized COVID-19 patients to be treated with hydroxychloroquine or chloroquine.